Effects of pancragen on the differentiation of pancreatic cells during their ageing.
Khavinson. V Kh VKh; Durnova. A O AO; Polyakova. V O VO; Tolibova. G H GH; Linkova. N S NS; Kvetnoy. I M IM; Kvetnaia. T V TV; Tarnovskaya. S I SI
Key Findings
- Pancragen increased expression of key differentiation markers in both acinar and islet cells.
- The effect was seen in both young and aged cell cultures, indicating potential anti‑ageing benefits for the pancreas.
Practical Outcomes
- For DIY health enthusiasts, the study points to a possible new target for supporting pancreatic health, but it does not provide dosage, safety, or human efficacy data. Until clinical trials are done, pancragen remains a research‑only peptide, so it’s not ready for self‑administration or protocol development.
Summary
A lab study found that the tiny peptide pancragen can boost the activity of genes that help pancreatic cells stay youthful and function properly, even in older cell cultures. This suggests it might help protect against diabetes and inflammation, but the work was done only in petri dishes, not in people.
Abstract
Expression of differentiation markers was found to be reduced during ageing of pancreatic cells. Tetrapeptide pancragen stimulates the expression of differentiation factors of acinar (Pdx1, Ptfla) and islet of Langerhans (Pdx1, Pax6, Pax4, Foxa2, NKx2.2) cells in "young" and " aged" cultures. Differentiation of acinar and islet pancreatic cells induced by pancragen can be a mechanism underlying its anti-diabetic and anti-inflammatory effects. Thus, transcription factors that regulate differentiation of pancreatic cells are a pharmacological target for pancragen, which allows considering it as an effective tool in the treatment of diabetes mellitus and pancreatitis.
Study Information
pubmed
2013
2013-02-01T00:00:00.000Z
10.1007/s10517-013-1987-6